Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Aronson

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BMJ Evidence-Based Medicine|November 28, 2019
Extending anticoagulation treatment for unprovoked venous thromboembolismCarl Heneghan, Jeffrey Aronson
British Journal of Clinical Pharmacology|June 7, 2019
Susceptibility to adverse drug reactionsRobin Ferner, Jeffrey Aronson
BMJ Evidence-Based Medicine|January 25, 2020
Forgotten Primodos story and the roles of general practitionersCarl Heneghan, Jeffrey Aronson
BMJ Evidence-Based Medicine|January 26, 2018
Catalogue of bias: attrition biasDavid Nunan, Jeffrey Aronson, Clare Bankhead
Lancet (London, England)|February 16, 2010
Reducing prescription errorsTony Weetman, Jeffrey Aronson, Simon Maxwell
BMJ Evidence-Based Medicine|November 15, 2019
Single screening or double screening for study selection in systematic reviews?Kamal R Mahtani, Carl Heneghan, Jeffrey Aronson
BMJ Evidence-Based Medicine|June 7, 2019
Single or dual antiplatelet therapy after a transient ischaemic attack or minor ischaemic stroke?Kamal R Mahtani, Carl Heneghan, Jeffrey Aronson
BMJ Evidence-Based Medicine|February 1, 2019
Introducing the EBM Verdict: research evidence relevant to clinical practiceCarl Heneghan, Jon Brassey, Jeffrey Aronson, et al.
British Journal of Clinical Pharmacology|February 25, 2012
Monitoring drug therapyThierry Buclin, Verena Gotta, Aline Fuchs, et al.
BMJ Evidence-Based Medicine|December 22, 2021
Preventable deaths from SARS-CoV-2 in England and Wales: a systematic case series of coroners' reports during the COVID-19 pandemicBethan Swift, Carl Heneghan, Jeffrey Aronson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMJ Evidence-Based Medicine|November 28, 2019
Extending anticoagulation treatment for unprovoked venous thromboembolismCarl Heneghan, Jeffrey Aronson
British Journal of Clinical Pharmacology|June 7, 2019
Susceptibility to adverse drug reactionsRobin Ferner, Jeffrey Aronson
BMJ Evidence-Based Medicine|January 25, 2020
Forgotten Primodos story and the roles of general practitionersCarl Heneghan, Jeffrey Aronson
BMJ Evidence-Based Medicine|January 26, 2018
Catalogue of bias: attrition biasDavid Nunan, Jeffrey Aronson, Clare Bankhead
Lancet (London, England)|February 16, 2010
Reducing prescription errorsTony Weetman, Jeffrey Aronson, Simon Maxwell
BMJ Evidence-Based Medicine|November 15, 2019
Single screening or double screening for study selection in systematic reviews?Kamal R Mahtani, Carl Heneghan, Jeffrey Aronson
BMJ Evidence-Based Medicine|June 7, 2019
Single or dual antiplatelet therapy after a transient ischaemic attack or minor ischaemic stroke?Kamal R Mahtani, Carl Heneghan, Jeffrey Aronson
BMJ Evidence-Based Medicine|February 1, 2019
Introducing the EBM Verdict: research evidence relevant to clinical practiceCarl Heneghan, Jon Brassey, Jeffrey Aronson, et al.
British Journal of Clinical Pharmacology|February 25, 2012
Monitoring drug therapyThierry Buclin, Verena Gotta, Aline Fuchs, et al.
BMJ Evidence-Based Medicine|December 22, 2021
Preventable deaths from SARS-CoV-2 in England and Wales: a systematic case series of coroners' reports during the COVID-19 pandemicBethan Swift, Carl Heneghan, Jeffrey Aronson, et al.
Pageof 2